NGL Fine-Chem Ltd. | Small-cap | Healthcare
₹1,000.00
0.00%
| NGL Fine-Chem Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 3.7B
Gross Profit 1.9B 50.47%
Operating Income 214.2M 5.82%
Net Income 211.2M 5.74%

Balance Sheet Metrics

Total Assets 4.3B
Total Liabilities 1.5B
Shareholders Equity 2.8B
Debt to Equity 0.53

Cash Flow Metrics

Operating Cash Flow 206.1M
Free Cash Flow -949.5M

Revenue & Profitability Trend

NGL Fine-Chem Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 3.7B 3.3B 2.7B 3.1B 2.6B
Cost of Goods Sold 1.8B 1.6B 1.4B 1.5B 1.0B
Gross Profit 1.9B 1.8B 1.3B 1.7B 1.5B
Operating Expenses 964.3M 791.1M 643.5M 660.3M 415.0M
Operating Income 214.2M 421.0M 236.7M 578.3M 763.3M
Pre-tax Income 277.1M 544.2M 273.6M 666.0M 775.9M
Income Tax 65.9M 131.0M 68.7M 167.0M 208.7M
Net Income 211.2M 413.2M 205.0M 499.0M 567.2M
EPS (Diluted) - ₹66.88 ₹33.18 ₹80.77 ₹91.81

Income Statement Trend

NGL Fine-Chem Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 2.4B 2.1B 1.6B 1.7B 1.2B
Non-Current Assets 2.0B 1.4B 1.2B 1.0B 828.6M
Total Assets 4.3B 3.6B 2.9B 2.8B 2.1B
Liabilities
Current Liabilities 1.2B 865.9M 582.9M 656.5M 417.7M
Non-Current Liabilities 319.9M 63.2M 62.4M 80.6M 111.6M
Total Liabilities 1.5B 929.0M 645.3M 737.1M 529.3M
Equity
Total Shareholders Equity 2.8B 2.6B 2.2B 2.0B 1.5B

Balance Sheet Composition

NGL Fine-Chem Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 277.1M 544.2M 273.6M 666.0M 775.9M
Operating Cash Flow 206.1M -30.6M 438.1M 128.5M 365.8M
Investing Activities
Capital Expenditures -737.6M -285.1M -303.1M -290.8M -170.7M
Investing Cash Flow -737.6M -285.1M -303.1M -290.8M -109.7M
Financing Activities
Dividends Paid -10.8M -10.8M -10.8M -10.8M -10.8M
Financing Cash Flow -10.8M -10.8M -10.8M -10.8M -10.8M
Free Cash Flow -949.5M -80.6M 38.8M -425.5M 101.4M

Cash Flow Trend

NGL Fine-Chem Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 30.67
Price to Book 2.30
Price to Sales 1.76

Profitability Ratios

Profit Margin 5.74%
Operating Margin 3.16%
Return on Equity 7.75%
Return on Assets 3.39%

Financial Health

Current Ratio 1.98
Debt to Equity 25.90
Beta 0.70

Per Share Data

EPS (TTM) ₹34.23
Book Value per Share ₹457.22
Revenue per Share ₹596.03

Financial data is updated regularly. All figures are in the company's reporting currency.